R. Guarisco

发表

Outcome Results of the Fosinopril Versus Amlodipine Cardiovascular Events Randomized Trial (FACET) in Patients With Hypertension and NIDDM

M. Pahor, R. Byington, F. Strollo, 1998, Diabetes Care.

On-treatment serum albumin level can guide long-term treatment in patients with cirrhosis and uncomplicated ascites.

A. Gasbarrini, A. Andrealli, P. Angeli, 2020, Journal of hepatology.

Quantitation of tissue polypeptide antigen (TPA) in hepatic and systemic circulation in patients with chronic liver diseases

R. Guarisco, F. Paglia, C. Puoti, 2009, Journal of gastroenterology and hepatology.

Hepatic venous pressure gradient does not correlate with the presence and the severity of portal hypertensive gastropathy in patients with liver cirrhosis.

R. Guarisco, L. Durola, C. Puoti, 2007, Journal of gastrointestinal and liver diseases : JGLD.

Rapid virological response as a predictor of sustained response in HCV‐infected patients with persistently normal alanine aminotransferase levels: A multicenter study

G. Barbarini, R. Guarisco, A. Nicolini, 2011, Journal of viral hepatitis.

HCV carriers with normal alanine aminotransferase levels: healthy persons or severely ill patients? Dealing with an everyday clinical problem.

R. Guarisco, C. Puoti, L. Bellis, 2010, European journal of internal medicine.

Occurrence of hepatocellular carcinoma in an apparently 'healthy' HCV patient.

R. Guarisco, L. Durola, C. Puoti, 2005, European journal of gastroenterology & hepatology.

An Unsuspected Factor Contributing to Pizza Hyperglycemia

P. Tatti, R. Guarisco, P. Di Mauro, 1993, Diabetes Care.

Long-term albumin administration improves survival in patients with decompensated cirrhosis: final results of the “ANSWER” study

A. Gasbarrini, E. Neri, G. Marín, 2017 .

Extrahepatic manifestations of chronic HCV infection.

R. Guarisco, C. Puoti, L. Bellis, 2007, Journal of gastrointestinal and liver diseases : JGLD.

Factors Enhancing Treatment of Hepatitis C Virus–Infected Italian People Who Use Drugs: The CLEO-GRECAS Experience

G. Barbarini, R. Sacco, T. Lupia, 2021, The American journal of gastroenterology.

Treatment of hepatitis C virus carriers with persistently normal alanine aminotransferase levels with peginterferon α‐2a and ribavirin: a multicentric study

G. Barbarini, R. Villani, R. Guarisco, 2009, Liver international : official journal of the International Association for the Study of the Liver.

Long-term albumin administration in decompensated cirrhosis (ANSWER): an open-label randomised trial

A. Gasbarrini, A. Andrealli, P. Angeli, 2018, The Lancet.

Liver biopsy in hepatitis C virus carriers with normal alanine aminotransferase levels

R. Guarisco, L. Bellis, Laudio Puoti, 2009, Hepatology.

Antiviral treatment of HCV carriers with persistently normal ALT levels.

R. Guarisco, C. Puoti, L. Bellis, 2008, Mini reviews in medicinal chemistry.

Chronic hepatitis C and 'normal' ALT levels: treat the disease not the test.

R. Guarisco, L. Durola, C. Puoti, 2005, Journal of hepatology.

Diagnosis, management, and treatment of hepatitis C

R. Guarisco, C. Puoti, L. Bellis, 2009, Hepatology.

Should we treat HCV carriers with normal ALT levels? The ‘5Ws’ dilemma

R. Guarisco, C. Puoti, L. Bellis, 2012, Journal of viral hepatitis.

Sustained virological response following extremely short antiviral treatment in selected HCV carriers with persistently normal ALT.

R. Guarisco, C. Puoti, L. Bellis, 2010, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.